Aryeh Jason
Transactions
50
Companies
10
Filings
12
CIK
0001376960
Recent Transactions
- Exercise/Conversion
- Exercise/Conversion
- Sale
- Sale
- Sale
- Purchase
Common Stock, par value $0.0001 per share
2025-09-19$2.45/sh+1,000→ 108,482 total - Award
Common Stock, par value $0.0001 per share ("Common Stock")
2025-08-07+15,000→ 107,482 total - Award
- Award
Common Stock, par value $0.0001 per share ("Common Stock")
2025-06-24+12,422→ 92,482 total - Award
- Award
Non-Qualified Stock Option (right to buy)
2025-06-06+5,783→ 5,783 total - Award
- Award
- Award
- Exercise/Conversion
Common Stock, par value $0.0001 per share ("Common Stock")
2024-12-27$4.30/sh+11,700→ 80,060 total - Exercise/Conversion
- Award
- Award
- Award
Common Stock, par value $0.0001 per share ("Common Stock")
2024-06-20+5,376→ 68,360 total - Award
- Award
Non-Qualified Stock Option (right to buy)
2024-06-14+5,444→ 5,444 total - Award
- Award
- Exercise/Conversion
- Exercise/Conversion
- Exercise/Conversion
- Exercise/Conversion
- Award
- Award
- Award
Non-Qualified Stock Option (right to buy)
2023-06-09+5,461→ 5,461 total - Exercise/Conversion
- Exercise/Conversion
Common Stock, par value $0.0001 per share ("Common Stock")
2023-04-12+11,246→ 62,984 total - Award
- Award
Nonstatutory Stock Option (Right to Buy)
2023-01-26+23,250→ 23,250 total - Award
Nonstatutory Stock Option (Right to Buy)
2023-01-26+6,975→ 6,975 total - Award
Common Stock, par value $0.0001 per share ("Common Stock")
2023-01-26+51,738→ 51,738 total - Award
Nonstatutory Stock Option (Right to Buy)
2023-01-26+23,250→ 23,250 total - Award
Nonstatutory Stock Option (Right to Buy)
2023-01-26+18,600→ 18,600 total - Award
Non-Qualified Stock Option (right to buy)
2022-12-22+4,484→ 4,484 total - Award
- Award
Non-Qualified Stock Option (right to buy)
2022-06-10+4,340→ 4,340 total - Award
- Award
- Award
Non-Qualified Stock Option (right to buy)
2021-06-04+3,269→ 3,269 total - Award
- Award
Non-Qualified Stock Option (right to buy)
2020-06-10+2,468→ 2,468 total - Purchase
- Purchase
- Purchase
- Purchase
Companies
10- $ANEB
Anebulo Pharmaceuticals, Inc.
Director
IMMUNOMEDICS INC
Director
- $LFCR
LIFECORE BIOMEDICAL, INC. \DE\
Director
- $LGND
LIGAND PHARMACEUTICALS INC
Director
MERRIMACK PHARMACEUTICALS INC
10% Owner, See Explanation of Responses
Myrexis, Inc.
Director
NOVELION THERAPEUTICS INC.
Director
Old API Wind-down Ltd.
Director
- $OBIO
Orchestra BioMed Holdings, Inc.
Director
- $VXRT
Vaxart, Inc.
Director
Recent Filings
12Address
34 SUMMER ROAD
GREENWICH, CT, 06831